THERAGENICS® BRACHYTHERAPY PRODUCTS

TheraSeed® Palladium 103, Model 200

TheraSeed® is a prostate brachytherapy seed manufactured with Palladium, or Pd-103, as the radioactive agent that attacks the localized cancer cells. The radioactive material is encapsulated within a biocompatible titanium casing. TheraSeed®’s radioactive material (Pd-103) has a half-life of 17 days, meaning it expends half of its energy between two to three weeks after implantation. Greater than 90 percent of the energy is expended within 90 days.


• Industry Benchmark
• Unrivaled, long-term clinical experience
• Exclusive design; distinctive concave end cups
• 16.9 day half life; 20-23 keV principle energy
• Widest range of available activities

 


AgX100® – Iodine 125, Model AgX 100

AgX100® is the newest brachytherapy seed offered by Theragenics. This iodine-based device performs similarly to TheraSeed®, but has a 60-day half life, meaning it expends half of its radioactive energy about two months after implantation. Greater than 90 percent of the activity is expended within 12 months.


• Designed after the recognized I-125 seed industry benchmark with long-term clinical experience
• Longer, more stable silver core for improved image clarity
• 59.4 day half life; 27-35 keV pinciple energy
• Widest range of available activities


Still have questions? Call us at 1-800-458-4372 to speak with one of our prostate cancer information specialists.